859 studies found for:    Open Studies | "Rectal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System
Condition: Colorectal Cancer
Intervention: Device: EndoVe endoscopic electroporation
22 Recruiting Korean Red Ginseng in Treating Patients With Fatigue Caused by Chemotherapy for Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Dietary Supplement: Korean Red Ginseng;   Dietary Supplement: Placebo
23 Recruiting Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients With RAS Wild-type Metastatic Colorectal Cancer)
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab;   Drug: FOLFIRI and cetuximab
24 Recruiting Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients
Conditions: Anal AIN3;   Anal Carcinoma
25 Recruiting The Effect of Physiotherapy for the Treatment of Fecal Incontinence.
Condition: Fecal Incontinence
Interventions: Behavioral: Individual supervised pelvic floor muscle exercises;   Other: Massage of the neck and back;   Behavioral: Standard information and guidance
26 Not yet recruiting Predictive Factors for Anastomotic Leakage After Colorectal Surgery
Conditions: Anastomotic Leakage;   Colorectal Cancer;   Anastomotic Leak;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Tumors
Intervention: Other: No interventions, only data collection
27 Recruiting Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin;   Drug: Folinic Acid;   Drug: 5-FU;   Drug: Irinotecan;   Drug: Bevacizumab;   Drug: Cetuximab
28 Recruiting Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy
Condition: Rectal Cancer
29 Unknown  A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab
30 Unknown  Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: capecitabine;   Drug: fluorouracil;   Drug: oxaliplatin
31 Not yet recruiting Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety and Efficacy Profiles of TSB-9-W1
Condition: Metastatic Colorectal Cancer
Intervention: Drug: TSB-9-W1
32 Recruiting Core Stability Program in Colorectal Cancer Survivors
Condition: Colorectal Cancer
Intervention: Other: core stability
33 Recruiting Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
Condition: Resectable Rectal Carcinoma
Interventions: Drug: FOLFOX4;   Radiation: Tomotherapy;   Procedure: TME (Total Mesorectal Excision)
34 Recruiting Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasm
Interventions: Drug: Selinexor;   Drug: Oxaliplatin;   Drug: 5-FU;   Drug: Folinic Acid
35 Recruiting Sequencing to Identify Gene Variants in Familial Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Genetic: gene sequencing
36 Recruiting Colorectal Cancer Umbrella Protocol
Condition: Colorectal Cancer
Interventions: Behavioral: Cancer Symptom Questionnaire;   Other: Biomarker Testing
37 Unknown  FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Conditions: Rectal Cancer;   Colon Cancer;   Metastasis;   Adenocarcinoma
Interventions: Drug: Hydroxychloroquine;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5-fluorouracil;   Drug: Bevacizumab
38 Recruiting GVAX for Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Biological: GVAX
39 Recruiting A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula
Conditions: Anal Fistula;   Rectal Fistula;   Fistula in Ano;   Transsphincteric Fistula
Intervention: Device: Strattice-LIFT
40 Recruiting Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: aflibercept + FOLFIRI

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years